24/7
Buzz
Startups
VC
AI
DefenseTech
Opinions
Events
Promising Startups 2026
2026 VC Survey
Boarding Pass
CTalk
BiblioTech
Corporate
Appointments
Tech Gateways
HR - The Next Leap
Ctech Testimonials
Projects
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Bristol-Myers Squib
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
DefenseTech
OPINIONS
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
12:22
Rafael and Lower Saxony strike deal to turn Volkswagen plant into defense center
12:12
Full list of Israeli high-tech funding rounds in 2026
12:09
Israeli startup raises $5 million to map the seabed with AI
11:50
“There’s more capital flowing into the market, but it is being concentrated among fewer companies”
More stories
Buzz
Most popular
Daily
Weekly
1
Wonderful is growing like Wiz, but its business is very different
2
U.S. airlines return to Israel as foreign carriers rebuild flight capacity
3
ServiceNow acquires Israeli AI startup Sweep in deal estimated at hundreds of millions
4
Israel’s academic isolation is becoming harder to ignore
5
Anthropic pushes back IPO as investors await one of AI’s biggest public-market tests
More news
Bristol-Myers Squib
2 stories about Bristol-Myers Squib
Immunai and Bristol Myers Squibb turn to AI to decode immune responses in clinical trials
15.01.26
|
CTech
The collaboration aims to improve understanding of patient biology in clinical trials.
Bristol-Myers Squibb Invests $12 Million in Israeli Immunotherapy Company Compugen
12.10.18
|
Dror Reich
The investment is part of a clinical trial collaboration for a treatment that combines Compugen’s investigational antibody with an immune checkpoint inhibitor from Bristol-Myers Squibb